These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2445439)

  • 41. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG; West DC; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Local cerebral consumption of glucose in the mouse. Adaptation of the 14C deoxyglucose method to free-moving small mammals].
    Nowaczyk T; Bobillier P; Jouvet M; des Rosiers MH
    C R Seances Acad Sci III; 1981 Jul; 293(1):79-83. PubMed ID: 6796204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversal of the actions of morphine on mesocortical dopamine metabolism in the rat by the kappa agonist MR-2034: tentative mu-2 opioid control of mesocortical dopaminergic projections.
    Kim HS; Iyengar S; Wood PL
    Life Sci; 1987 Oct; 41(14):1711-5. PubMed ID: 2821337
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative measurement of local cerebral metabolic rate for glucose utilizing tritiated 2-deoxyglucose.
    Alexander GM; Schwartzman RJ; Bell RD; Yu J; Renthal A
    Brain Res; 1981 Oct; 223(1):59-67. PubMed ID: 7284810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effects of mu and kappa opioid systems on motivational processes.
    Shippenberg TS; Herz A
    NIDA Res Monogr; 1986; 75():563-66. PubMed ID: 2829003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic rate in different rat brain areas during seizures induced by a specific delta opiate receptor agonist.
    Haffmans J; De Kloet R; Dzoljic MR
    Brain Res; 1984 Jun; 302(1):111-5. PubMed ID: 6329455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Butorphanol and nalbuphine: a pharmacologic comparison.
    Pallasch TJ; Gill CJ
    Oral Surg Oral Med Oral Pathol; 1985 Jan; 59(1):15-20. PubMed ID: 2983281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antinociceptive profiles of mu and kappa opioid agonists in a rat tooth pulp stimulation procedure.
    Steinfels GF; Cook L
    J Pharmacol Exp Ther; 1986 Jan; 236(1):111-7. PubMed ID: 2867210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors.
    Peng X; Knapp BI; Bidlack JM; Neumeyer JL
    J Med Chem; 2007 May; 50(9):2254-8. PubMed ID: 17407276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pressor effect of nalbuphine in hemorrhagic shock is dependent on the sympathoadrenal system.
    Muldoon SM; McKenzie JE; Collins FJ
    Circ Shock; 1988 Sep; 26(1):89-98. PubMed ID: 2847883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A sequential double-label autoradiographic method that quantifies altered rates of regional glucose metabolism.
    Olds JL; Frey KA; Ehrenkaufer RL; Agranoff BW
    Brain Res; 1985 Dec; 361(1-2):217-24. PubMed ID: 4084794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antagonist effects of nalbuphine in opioid-dependent human volunteers.
    Preston KL; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1989 Mar; 248(3):929-37. PubMed ID: 2467983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 2-Deoxyglucose incorporation into rat brain glycogen during measurement of local cerebral glucose utilization by the 2-deoxyglucose method.
    Nelson T; Kaufman EE; Sokoloff L
    J Neurochem; 1984 Oct; 43(4):949-56. PubMed ID: 6470715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
    Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
    J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoradiographic imaging of rat sarcoma in different anatomical sites using 2-[14C]deoxyglucose.
    Kern KA; Norton JA
    Cancer Res; 1987 Sep; 47(17):4706-8. PubMed ID: 3621165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the mixed mu/kappa opioid nalbuphine on cocaine-induced changes in subjective and cardiovascular responses in men.
    Mello NK; Mendelson JH; Sholar MB; Jaszyna-Gasior M; Goletiani N; Siegel AJ
    Neuropsychopharmacology; 2005 Mar; 30(3):618-32. PubMed ID: 15602503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Failure of nalbuphine to antagonize morphine: a double-blind comparison with naloxone.
    Bailey PL; Clark NJ; Pace NL; Isern M; Stanley TH
    Anesth Analg; 1986 Jun; 65(6):605-11. PubMed ID: 3085551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of the cerebral uptake and metabolism of labeled glucose and deoxyglucose in vivo in rats.
    Sacks W; Sacks S; Fleischer A
    Neurochem Res; 1983 May; 8(5):661-85. PubMed ID: 6888655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.